Publication:
Mortality and host response aberrations associated with transient and persistent acute kidney injury in critically ill patients with sepsis: a prospective cohort study

dc.contributor.authorFabrice Uhelen_US
dc.contributor.authorHessel Peters-Sengersen_US
dc.contributor.authorFahimeh Falahien_US
dc.contributor.authorBrendon P. Sciclunaen_US
dc.contributor.authorLonneke A. van Vughten_US
dc.contributor.authorMarc J. Bontenen_US
dc.contributor.authorOlaf L. Cremeren_US
dc.contributor.authorMarcus J. Schultzen_US
dc.contributor.authorTom van der Pollen_US
dc.contributor.otherUniversity Medical Center Utrechten_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherNuffield Department of Medicineen_US
dc.contributor.otherAmsterdam UMC - University of Amsterdamen_US
dc.date.accessioned2020-08-25T10:26:10Z
dc.date.available2020-08-25T10:26:10Z
dc.date.issued2020-08-01en_US
dc.description.abstract© 2020, The Author(s). Purpose: Sepsis is the most frequent cause of acute kidney injury (AKI). The “Acute Disease Quality Initiative Workgroup” recently proposed new definitions for AKI, classifying it as transient or persistent. We investigated the incidence, mortality, and host response aberrations associated with transient and persistent AKI in sepsis patients. Methods: A total of 1545 patients admitted with sepsis to 2 intensive care units in the Netherlands were stratified according to the presence (defined by any urine or creatinine RIFLE criterion within the first 48 h) and evolution of AKI (with persistent defined as remaining > 48 h). We determined 30-day mortality by logistic regression adjusting for confounding variables and analyzed 16 plasma biomarkers reflecting pathways involved in sepsis pathogenesis (n = 866) and blood leukocyte transcriptomes (n = 392). Results: AKI occurred in 37.7% of patients, of which 18.4% was transient and 81.6% persistent. On admission, patients with persistent AKI had higher disease severity scores and more frequently had severe (injury or failure) RIFLE AKI stages than transient AKI patients. Persistent AKI, but not transient AKI, was associated with increased mortality by day 30 and up to 1 year. Persistent AKI was associated with enhanced and sustained inflammatory and procoagulant responses during the first 4 days, and a more severe loss of vascular integrity compared with transient AKI. Baseline blood gene expression showed minimal differences with respect to the presence or evolution of AKI. Conclusion: Persistent AKI is independently associated with sepsis mortality, as well as with sustained inflammatory and procoagulant responses, and loss of vascular integrity as compared with transient AKI.en_US
dc.identifier.citationIntensive Care Medicine. Vol.46, No.8 (2020), 1576-1589en_US
dc.identifier.doi10.1007/s00134-020-06119-xen_US
dc.identifier.issn14321238en_US
dc.identifier.issn03424642en_US
dc.identifier.other2-s2.0-85086176914en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/58045
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086176914&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleMortality and host response aberrations associated with transient and persistent acute kidney injury in critically ill patients with sepsis: a prospective cohort studyen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086176914&origin=inwarden_US

Files

Collections